Lit-OTAR framework for extracting biological evidences from literature.

Santosh Tirunagari, Shyamasree Saha, Aravind Venkatesan, Daniel Suveges, Miguel Carmona, Annalisa Buniello, David Ochoa, Johanna McEntyre, Ellen McDonagh, Melissa Harrison
{"title":"Lit-OTAR framework for extracting biological evidences from literature.","authors":"Santosh Tirunagari, Shyamasree Saha, Aravind Venkatesan, Daniel Suveges, Miguel Carmona, Annalisa Buniello, David Ochoa, Johanna McEntyre, Ellen McDonagh, Melissa Harrison","doi":"10.1093/bioinformatics/btaf113","DOIUrl":null,"url":null,"abstract":"<p><strong>Summary: </strong>The lit-OTAR framework, developed through a collaboration between Europe PMC and Open Targets, leverages deep learning to revolutionize drug discovery by extracting evidence from scientific literature for drug target identification and validation. This novel framework combines named entity recognition for identifying gene/protein (target), disease, organism, and chemical/drug within scientific texts, and entity normalization to map these entities to databases like Ensembl, Experimental Factor Ontology, and ChEMBL. Continuously operational, it has processed over 39 million abstracts and 4.5 million full-text articles and preprints to date, identifying more than 48.5 million unique associations that significantly help accelerate the drug discovery process and scientific research >29.9 m distinct target-disease, 11.8 m distinct target-drug, and 8.3 m distinct disease-drug relationships.</p><p><strong>Availability and implementation: </strong>The results are accessible through Europe PMC's SciLite web app (https://europepmc.org/) and its annotations API (https://europepmc.org/annotationsapi), as well as via the Open Targets Platform (https://platform.opentargets.org/). The daily pipeline is available at https://github.com/ML4LitS/otar-maintenance, and the Open Targets ETL processes are available at https://github.com/opentargets.</p>","PeriodicalId":93899,"journal":{"name":"Bioinformatics (Oxford, England)","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11978389/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformatics (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bioinformatics/btaf113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Summary: The lit-OTAR framework, developed through a collaboration between Europe PMC and Open Targets, leverages deep learning to revolutionize drug discovery by extracting evidence from scientific literature for drug target identification and validation. This novel framework combines named entity recognition for identifying gene/protein (target), disease, organism, and chemical/drug within scientific texts, and entity normalization to map these entities to databases like Ensembl, Experimental Factor Ontology, and ChEMBL. Continuously operational, it has processed over 39 million abstracts and 4.5 million full-text articles and preprints to date, identifying more than 48.5 million unique associations that significantly help accelerate the drug discovery process and scientific research >29.9 m distinct target-disease, 11.8 m distinct target-drug, and 8.3 m distinct disease-drug relationships.

Availability and implementation: The results are accessible through Europe PMC's SciLite web app (https://europepmc.org/) and its annotations API (https://europepmc.org/annotationsapi), as well as via the Open Targets Platform (https://platform.opentargets.org/). The daily pipeline is available at https://github.com/ML4LitS/otar-maintenance, and the Open Targets ETL processes are available at https://github.com/opentargets.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从文献中提取生物学证据的Lit-OTAR框架。
摘要:lit-OTAR框架是由欧洲PMC和Open Targets合作开发的,通过从科学文献中提取药物靶点识别和验证的证据,利用深度学习来彻底改变药物发现。这个新框架结合了命名实体识别(NER),用于识别科学文本中的基因/蛋白质(目标)、疾病、生物体和化学/药物,以及实体规范化,将这些实体映射到诸如Ensembl、实验因子本体(EFO)和ChEMBL等数据库。迄今为止,它已处理了超过3900万篇摘要和450万篇全文文章和预印本,确定了超过4850万个独特的关联,这些关联极大地帮助加快了药物发现过程和科学研究(29.9个不同的目标疾病,11.8个不同的目标药物和8.3个不同的疾病-药物关系)。可用性和实施:结果可通过欧洲PMC的SciLite web应用程序(https://europepmc.org/)及其注释API (https://europepmc.org/annotationsapi)以及开放目标平台(https://platform.opentargets.org/)访问。每日管道可在https://github.com/ML4LitS/otar-maintenance上获得,开放目标ETL流程可在https://github.com/opentargets.Supplementary上获得:补充数据可在Bioinformatics在线获得。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
NAViFluX: a visualization‑centric platform for interactive analysis, refinement and design of genome‑scale metabolic networks. Reconstructing cell-cell interaction network in single-cell spatial transcriptomics via directed heterogeneous graph autoencoder. HySimODE: A hybrid stochastic-deterministic simulation framework for multiscale models of biological systems. BABAPPAlign: A Multiple Sequence Alignment Engine with a Learned Residue-Level Scoring Function. A Large-Scale Neutral Comparison Study of Survival Models on Low-Dimensional Data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1